Skip to content
healthcare.dev

Revlimid

NDC 59572-402, Lenalidomide, capsule, from Celgene Corporation.

Product NDC
59572-402
Status
Listed
Labeler
Celgene Corporation
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA021880
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59572-402 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LENALIDOMIDE2.5 mg/1

Pharmacologic classes

Thalidomide Analog [EPC]

Package NDCNDC-11Package
59572-402-0059572040200100 CAPSULE in 1 BOTTLE (59572-402-00)
59572-402-285957204022828 CAPSULE in 1 BOTTLE (59572-402-28)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5fa97bf5-28a2-48f1-8955-f56012d296be

Use it

Look up 59572-402 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59572-402 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59572-402. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.